Immunotherapy of multiple sclerosis:: Where are we?: Where should we go?

被引：60
|
作者：
Martin, R
Stürzebecher, CS
McFarland, HF
机构：
[1] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[2] Schering AG, Clin Dev CNS, D-13342 Berlin, Germany
来源：
NATURE IMMUNOLOGY | 2001年 / 2卷 / 09期
关键词：
D O I：
10.1038/ni0901-785
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Differences in multiple sclerosis patient's disease and their responses to standard drugs indicate that today's therapies need to be more individualized. It is proposed that gene expression profiling in conjunction with magnetic resonance imaging be used to optimize future treatment approaches.
引用
收藏
页码：785 / 788
页数：4
相关论文
共 50 条
  • [41] Catfish Sampling Techniques: Where We Are Now and Where We Should Go
    Bodine, Kristopher A.
    Shoup, Daniel E.
    Olive, Jason
    Ford, Zachary L.
    Krogman, Rebecca
    Stubbs, Tyler J.
    FISHERIES, 2013, 38 (12) : 529 - 546
  • [42] Dissemination research in cancer control: where are we and where should we go?
    Deborah J. Bowen
    Glorian Sorensen
    Bryan J. Weiner
    Marci Campbell
    Karen Emmons
    Cathy Melvin
    Cancer Causes & Control, 2009, 20 : 473 - 485
  • [43] CHEST PAIN OF ESOPHAGEAL ORIGIN - WHERE ARE WE, AND WHERE SHOULD WE GO
    BENJAMIN, SB
    CASTELL, DO
    ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (04) : 772 - 776
  • [44] Personalized medicine and healthcare: where are we now, where should we go?
    Laszlo, Gulacsi
    Szabolcs, Bekassy
    Nora, Bittner
    Judit, Feith Helga
    Andrea, Ficzere
    Lajos, Horvath
    Zsolt, Horvath
    Ico, Toth
    Zsombor, Zrubka
    Erika, Toth
    Gabor, Kovacs L.
    ORVOSI HETILAP, 2023, 164 (06) : 202 - 209
  • [45] Smart energy: where do we stand and where should we go?
    Kranz, Johann
    Kolbe, Lutz M.
    Koo, Chulmo
    Boudreau, Marie-Claude
    ELECTRONIC MARKETS, 2015, 25 (01) : 7 - 16
  • [46] Digital Skills in Contemporary Schools - Where We Are and Where We Should Go
    Pyzalski, Jacek
    NEW MEDIA PEDAGOGY: RESEARCH TRENDS, METHODOLOGICAL CHALLENGES, AND SUCCESSFUL IMPLEMENTATIONS, NMP 2023, 2024, 2130 : 75 - 84
  • [47] Digital human resource development: where are we? Where should we go and how do we go there?
    Thite, Mohan
    HUMAN RESOURCE DEVELOPMENT INTERNATIONAL, 2022, 25 (01) : 87 - 103
  • [48] Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?
    Luo, Xunrong
    Herold, Kevan C.
    Miller, Stephen D.
    IMMUNITY, 2010, 32 (04) : 488 - 499
  • [49] The Future of IBD Therapy: Where Are We and Where Should We Go Next?
    Mao, Ren
    Hu, Pin-Jin
    DIGESTIVE DISEASES, 2016, 34 (1-2) : 175 - 179
  • [50] Where we should be and where we are
    Corral De la Calle, M. A.
    RADIOLOGIA, 2010, 52 (03): : 193 - 195
12345